(CNSNews.com) – A federally funded program at Harvard University is offering “humanized mice” made with organs taken from aborted babies for prices ranging from $800 to $1,272, according to the fee schedule Harvard has published online.
This program, which has received $926,682 in grants from the National Institutes of Health over the past 5 years, creates a demand for tissue—including livers and thymuses–taken from aborted babies.
Its current grant of $168,320 was awarded for a one-year period that started on Aug. 1, 2018 and will end on July 31, 2019.
On May 15, CNSNews.com asked NIH and the Department of Health and Services: “Will the NIH extend this grant beyond July 31, 2019? Or will NIH terminate this grant?”
On June 21, HHS indicated to CNSNews.com that this program and another federally funded Harvard program that uses tissue from aborted babies to make humanized mice will not be immediately subject to the new policy announced by the administration earlier this month that requires “extramural” HHS-funded programs that use fetal tissue to undergo a new layer of review by an ethics advisory board.
“The grants you reference went through the competitive renewal cycle prior to the announcement of the new policy,” an HHS spokesperson told CNSNews.com on Friday.
CNSNews.com followed up on that statement from HHS by asking: “Does the fact that they went through the competitive renewal cycle before HHS announced its new policy mean that Harvard’s Humanized Mouse Core must have its grant renewed for another year when it expires at the end of July and that the Core B: Animal and Laboratory Core must have its funding renewed when its current funding period ends at the end of March 2020? Can they be cancelled at the end of their current funding periods?”
“We cannot generally terminate a grant if it’s up for a non-competitive renewal in 2020,” HHS responded.